Crinetics Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $143 | $1,031 | $361 | $0 |
Gross Profit | -90,321 | 1,031 | 361 | 188 |
EBITDA | -141,574 | -128,153 | -110,480 | -93,957 |
EBIT | -142,586 | -129,112 | -111,405 | -94,745 |
Net Income | -130,091 | -115,637 | -96,774 | -80,595 |
Net Change In Cash | 143 | 1,031 | 361 | 0 |
Free Cash Flow | -111,581 | -89,053 | -89,691 | -65,703 |
Cash | 111,401 | 53,726 | 94,569 | 264,545 |
Basic Shares | 94,215 | 93,791 | 93,102 | 91,494 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $1,039 | $4,013 | $4,737 | $1,078 |
Gross Profit | -1,746 | 4,013 | 4,737 | 1,078 |
EBITDA | -336,069 | -221,510 | -166,899 | -106,780 |
EBIT | -338,854 | -222,608 | -167,882 | -107,702 |
Net Income | -298,408 | -214,529 | -159,954 | -106,719 |
Net Change In Cash | 1,039 | 4,013 | 4,737 | 1,078 |
Free Cash Flow | -229,814 | -170,995 | -116,861 | -89,024 |
Cash | 264,545 | 54,897 | 32,672 | 200,695 |
Basic Shares | 80,783 | 58,071 | 51,982 | 38,436 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$1.38 |
2025-06-30 | -$1.23 |
2025-03-31 | -$1.04 |
